• Je něco špatně v tomto záznamu ?

Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys

P. Winkler, T. Formanek, K. Mlada, A. Kagstrom, Z. Mohrova, P. Mohr, L. Csemy,

. 2020 ; 29 (-) : e173. [pub] 20200929

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20027803

AIMS: The United Nations warned of COVID-19-related mental health crisis; however, it is unknown whether there is an increase in the prevalence of mental disorders as existing studies lack a reliable baseline analysis or they did not use a diagnostic measure. We aimed to analyse trends in the prevalence of mental disorders prior to and during the COVID-19 pandemic. METHODS: We analysed data from repeated cross-sectional surveys on a representative sample of non-institutionalised Czech adults (18+ years) from both November 2017 (n = 3306; 54% females) and May 2020 (n = 3021; 52% females). We used Mini International Neuropsychiatric Interview (MINI) as the main screening instrument. We calculated descriptive statistics and compared the prevalence of current mood and anxiety disorders, suicide risk and alcohol-related disorders at baseline and right after the first peak of COVID-19 when related lockdown was still in place in CZ. In addition, using logistic regression, we assessed the association between COVID-19-related worries and the presence of mental disorders. RESULTS: The prevalence of those experiencing symptoms of at least one current mental disorder rose from a baseline of 20.02 (95% CI = 18.64; 21.39) in 2017 to 29.63 (95% CI = 27.9; 31.37) in 2020 during the COVID-19 pandemic. The prevalence of both major depressive disorder (3.96, 95% CI = 3.28; 4.62 v. 11.77, 95% CI = 10.56; 12.99); and suicide risk (3.88, 95% CI = 3.21; 4.52 v. 11.88, 95% CI = 10.64; 13.07) tripled and current anxiety disorders almost doubled (7.79, 95% CI = 6.87; 8.7 v. 12.84, 95% CI = 11.6; 14.05). The prevalence of alcohol use disorders in 2020 was approximately the same as in 2017 (10.84, 95% CI = 9.78; 11.89 v. 9.88, 95% CI = 8.74; 10.98); however, there was a significant increase in weekly binge drinking behaviours (4.07% v. 6.39%). Strong worries about both, health or economic consequences of COVID-19, were associated with an increased odds of having a mental disorder (1.63, 95% CI = 1.4; 1.89 and 1.42, 95% CI = 1.23; 1.63 respectively). CONCLUSIONS: This study provides evidence matching concerns that COVID-19-related mental health problems pose a major threat to populations, particularly considering the barriers in service provision posed during lockdown. This finding emphasises an urgent need to scale up mental health promotion and prevention globally.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027803
003      
CZ-PrNML
005      
20240626151037.0
007      
ta
008      
210105e20200929xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1017/S2045796020000888 $2 doi
035    __
$a (PubMed)32988427
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Winkler, P $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic. Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, David Goldberg Centre, De Crespigny Park, London SE5 8AF, UK.
245    10
$a Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys / $c P. Winkler, T. Formanek, K. Mlada, A. Kagstrom, Z. Mohrova, P. Mohr, L. Csemy,
520    9_
$a AIMS: The United Nations warned of COVID-19-related mental health crisis; however, it is unknown whether there is an increase in the prevalence of mental disorders as existing studies lack a reliable baseline analysis or they did not use a diagnostic measure. We aimed to analyse trends in the prevalence of mental disorders prior to and during the COVID-19 pandemic. METHODS: We analysed data from repeated cross-sectional surveys on a representative sample of non-institutionalised Czech adults (18+ years) from both November 2017 (n = 3306; 54% females) and May 2020 (n = 3021; 52% females). We used Mini International Neuropsychiatric Interview (MINI) as the main screening instrument. We calculated descriptive statistics and compared the prevalence of current mood and anxiety disorders, suicide risk and alcohol-related disorders at baseline and right after the first peak of COVID-19 when related lockdown was still in place in CZ. In addition, using logistic regression, we assessed the association between COVID-19-related worries and the presence of mental disorders. RESULTS: The prevalence of those experiencing symptoms of at least one current mental disorder rose from a baseline of 20.02 (95% CI = 18.64; 21.39) in 2017 to 29.63 (95% CI = 27.9; 31.37) in 2020 during the COVID-19 pandemic. The prevalence of both major depressive disorder (3.96, 95% CI = 3.28; 4.62 v. 11.77, 95% CI = 10.56; 12.99); and suicide risk (3.88, 95% CI = 3.21; 4.52 v. 11.88, 95% CI = 10.64; 13.07) tripled and current anxiety disorders almost doubled (7.79, 95% CI = 6.87; 8.7 v. 12.84, 95% CI = 11.6; 14.05). The prevalence of alcohol use disorders in 2020 was approximately the same as in 2017 (10.84, 95% CI = 9.78; 11.89 v. 9.88, 95% CI = 8.74; 10.98); however, there was a significant increase in weekly binge drinking behaviours (4.07% v. 6.39%). Strong worries about both, health or economic consequences of COVID-19, were associated with an increased odds of having a mental disorder (1.63, 95% CI = 1.4; 1.89 and 1.42, 95% CI = 1.23; 1.63 respectively). CONCLUSIONS: This study provides evidence matching concerns that COVID-19-related mental health problems pose a major threat to populations, particularly considering the barriers in service provision posed during lockdown. This finding emphasises an urgent need to scale up mental health promotion and prevention globally.
650    _2
$a dospělí $7 D000328
650    _2
$a poruchy způsobené alkoholem $x epidemiologie $x etiologie $7 D019973
650    _2
$a úzkostné poruchy $x epidemiologie $x etiologie $7 D001008
650    _2
$a Betacoronavirus $7 D000073640
650    _2
$a COVID-19 $7 D000086382
650    _2
$a koronavirové infekce $x epidemiologie $x psychologie $7 D018352
650    _2
$a průřezové studie $7 D003430
650    _2
$a depresivní porucha unipolární $x epidemiologie $x etiologie $7 D003865
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a duševní poruchy $x epidemiologie $x etiologie $7 D001523
650    _2
$a duševní zdraví $x statistika a číselné údaje $7 D008603
650    _2
$a lidé středního věku $7 D008875
650    _2
$a poruchy nálady $x epidemiologie $x etiologie $7 D019964
650    _2
$a pandemie $7 D058873
650    _2
$a virová pneumonie $x epidemiologie $x psychologie $7 D011024
650    _2
$a prevalence $7 D015995
650    _2
$a psychiatrické posuzovací škály $7 D011569
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a sebevražda $x statistika a číselné údaje $7 D013405
650    _2
$a průzkumy a dotazníky $7 D011795
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Formánek, Tomáš $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic. $7 xx0319355
700    1_
$a Mlada, K $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic. Faculty of Medicine in Pilsen, Charles University, Husova 3, 301 00Pilsen, Czech Republic.
700    1_
$a Kagstrom, A $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
700    1_
$a Mohrova, Z $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
700    1_
$a Mohr, P $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic. Third Faculty of Medicine, Charles University, Ruska 87, 100 00Prague, Czech Republic.
700    1_
$a Csemy, L $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
773    0_
$w MED00205906 $t Epidemiology and psychiatric sciences $x 2045-7979 $g Roč. 29 (20200929), s. e173
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32988427 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20240626151032 $b ABA008
999    __
$a ok $b bmc $g 1608138 $s 1118983
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 29 $c - $d e173 $e 20200929 $i 2045-7979 $m Epidemiology and psychiatric sciences $n Epidemiol Psychiatr Sci $x MED00205906
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...